diabetes
Conditions
Interventions
intervention group:The intervention group integrates the knowledge graph-based Diabetes Relief Solution Recommendation System (DRSRS) on the basis of SDPC, and realizes multi-dimensional intervention
support patients to upload real-time physiological indicators (blood glucose, blood pressure), lifestyle data (dietary records, length of exercise) and medication information, and generate visualized
set up an intelligent reminder function in combination with the individualized needs of the patient, push medication and blood glucose monitoring tips at regular intervals and dynamically optimize the
control group:The control group received the standard diabetes management program (SDPC), including routine medical services provided by community physicians, such as regular follow-up visits (every 3
Sponsors
Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis: meet the WHO or ADA diagnostic criteria for type 2 diabetes mellitus (meet any of the following): (1) Fasting blood glucose >=7.0 mmol/L; (2) 2-hour postprandial blood glucose >=11.1 mmol/L; (3)HbA1c>=6.5%; (4) Current HbA1c >=7.0% (poor glycemic control). 2. Demographic characteristics: (1) Age 18-75 years old; (2) Continuously residing in Nanjing for > = 1 year, and have no relocation plan in the next 2 years. 3. Technical adaptability: (1) Proficient in the use of smart phones (install the customized app of this study) and social tools such as WeChat (for health data synchronization and follow-up). 4. Treatment background: (1) No adjustment of insulin treatment regimen within 3 months prior to enrollment; (2) Not participating in other diabetes intervention trials. 5. Informed consent: (1) Voluntarily signed the informed consent form and promised to complete the 6-month follow-up.
Exclusion criteria
Exclusion criteria: 1. Diabetes classification and complications: (1) Type 1 diabetes, gestational diabetes or secondary diabetes (such as post-pancreatitis diabetes); (2) Complications of severe diabetes: 1) Diabetic nephropathy (eGFR<30 ml/min/1.73m²); 2) proliferative retinopathy; 3) NYHA Class III-IV heart failure. 2. Conflict between comorbidities and treatment: (1) Active malignant tumor or chemoradiotherapy in the past 6 months; (2) Long-term use of glucocorticoids or other drugs that affect blood glucose metabolism is required. 3. Cognitive and behavioral limitations: (1) Diagnosed Alzheimer's disease, severe cognitive impairment (MMSE score <18) or psychiatric illness (such as schizophrenia); (2) History of alcohol or drug dependence (affecting compliance). 4. Technical or language barriers: (1) Unable to complete the Chinese version of the electronic questionnaire filling or App operation training.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c change value;Diabetes remission rate; | — |
Countries
China
Contacts
Public ContactDoudou Li
Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine
Outcome results
None listed